Cargando…

Outcome of patients with HIV-related germ cell tumours: a case–control study

Testicular germ cell tumour (GCT) is not an AIDS-defining illness despite an increased incidence in men with HIV infection. We performed a matched case-control study comparing outcomes in HIV-positive men and the general population with GCT, using three age and stage matched controls for each case....

Descripción completa

Detalles Bibliográficos
Autores principales:	Powles, T, Bower, M, Shamash, J, Stebbing, J, Ong, J, Daugaard, G, De Ruiter, A, Johnson, M, Fisher, M, Anderson, J, Nelson, M, Gazzard, B, Oliver, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2004
Materias:	Clinical
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409707/ https://www.ncbi.nlm.nih.gov/pubmed/15083180 http://dx.doi.org/10.1038/sj.bjc.6601762

Ejemplares similares

Does HIV adversely influence the outcome in advanced non-small-cell lung cancer in the era of HAART?
por: Powles, T, et al.
Publicado: (2003)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours
por: Shamash, J, et al.
Publicado: (2007)

Accelerated BEP: a phase I trial of dose-dense BEP for intermediate and poor prognosis metastatic germ cell tumour
por: Rimmer, Y, et al.
Publicado: (2011)

New concepts in anti-HIV therapies
por: Stebbing, Justin, et al.
Publicado: (2006)

Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group
por: Powles, T, et al.
Publicado: (2003)

Serum lactate dehydrogenase isoenzyme 1 as a prognostic predictor for metastatic testicular germ cell tumours – reply
por: Shamash, J
Publicado: (2000)

Prediction of relapse after lymph node dissection for germ cell tumours: can salvage chemotherapy be avoided?
por: Berney, D M, et al.
Publicado: (2001)

A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia
por: Powles, T, et al.
Publicado: (2007)

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
por: Powles, T, et al.
Publicado: (2006)

The significance of the time interval between antecedent pregnancy and diagnosis of high-risk gestational trophoblastic tumours
por: Powles, T, et al.
Publicado: (2006)

Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours
por: McNeish, I A, et al.
Publicado: (2004)

Subjective quality of life and sexual functioning after germ-cell tumour therapy
por: Fegg, M J, et al.
Publicado: (2003)

Pre-induction LDH as a prognostic factor for outcome of high dose chemotherapy (HDCT) for germ cell tumours relapsing or refractory to conventional chemotherapy
por: Shamash, J, et al.
Publicado: (2000)

Bilateral germ-cell tumours: 22-year experience at the Institut Gustave Roussy
por: Theodore, Ch, et al.
Publicado: (2004)

The efficacy and safety of irinotecan cisplatin and mitomycin chemotherapy in sunitinib pre-treated metastatic clear cell renal cancer
por: Powles, Thomas, et al.
Publicado: (2008)

Alternating dose-dense chemotherapy in patients with high volume disseminated non-seminomatous germ cell tumours
por: Fizazi, K, et al.
Publicado: (2002)

Concomitant aortocaval resection for germ cell tumour
por: Rohila, Jitender, et al.
Publicado: (2020)

Somatic mutations of KIT in familial testicular germ cell tumours
por: Rapley, E A, et al.
Publicado: (2004)

A multicentre retrospective cohort study of ovarian germ cell tumours: Evidence for chemotherapy de-escalation and alignment of paediatric and adult practice
por: Newton, C., et al.
Publicado: (2019)

Salvage high-dose chemotherapy for children with extragonadal germ-cell tumours
por: De Giorgi, U, et al.
Publicado: (2005)

Infertility rates following POMB/ACE chemotherapy for male and female germ cell tumours – a retrospective long-term follow-up study
por: Gaffan, J, et al.
Publicado: (2003)

Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors
por: Willemse, P M, et al.
Publicado: (2013)

IGF signalling in germ cells and testicular germ cell tumours: roles and therapeutic approaches
por: Selfe, J., et al.
Publicado: (2019)

High-dose therapy including carboplatin adjusted for renal function in patients with relapsed or refractory germ cell tumour: outcome and prognostic factors.
por: Lyttelton, M. P., et al.
Publicado: (1998)

DNA topoisomerase I and II expression in drug resistantgerm cell tumours
por: Berney, D M, et al.
Publicado: (2002)

A multi-centre randomised phase III trial of Dexamethasone vs Dexamethasone and diethylstilbestrol in castration-resistant prostate cancer: immediate vs deferred Diethylstilbestrol
por: Shamash, J, et al.
Publicado: (2011)

Safety and efficacy of resistance training in germ cell cancer patients undergoing chemotherapy: a randomized controlled trial
por: Christensen, J F, et al.
Publicado: (2014)

Novel compounds with antiangiogenic and antiproliferative potency for growth control of testicular germ cell tumours
por: Nitzsche, B, et al.
Publicado: (2010)

IPM chemotherapy in cytokine refractory renal cell cancer
por: Shamash, J, et al.
Publicado: (2003)

Prognostic factors and outcomes of nonseminomatous germ cell tumours of testis—experience from a tertiary cancer centre in India
por: Nair, Lekha Madhavan, et al.
Publicado: (2020)

Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT)
por: Bono, J S de, et al.
Publicado: (2000)

A phase II study investigating the re-induction of endocrine sensitivity following chemotherapy in androgen-independent prostate cancer
por: Shamash, J, et al.
Publicado: (2008)

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial
por: Bokemeyer, C, et al.
Publicado: (2003)

Development of a best-practice clinical guideline for the use of bleomycin in the treatment of germ cell tumours in the UK
por: Watson, Robert A., et al.
Publicado: (2018)

Increased mortality rates in young and middle-aged patients with malignant germ cell tumours
por: Fosså, S D, et al.
Publicado: (2004)

The effect of early pregnancy following chemotherapy on disease relapse and foetal outcome in women treated for gestational trophoblastic tumours
por: Blagden, S P, et al.
Publicado: (2002)

A pipeline to quantify serum and cerebrospinal fluid microRNAs for diagnosis and detection of relapse in paediatric malignant germ-cell tumours
por: Murray, Matthew J, et al.
Publicado: (2016)

Bleomycin, vincristine, cisplatin/bleomycin, etoposide, cisplatin chemotherapy: an alternating, dose intense regimen producing promising results in untreated patients with intermediate or poor prognosis malignant germ-cell tumours
por: Anthoney, D A, et al.
Publicado: (2004)

Irinotecan, cisplatin and mitomycin in inoperable gastro-oesophageal and pancreatic cancers – a new active regimen
por: Slater, S, et al.
Publicado: (2002)

Cannot write session to /tmp/vufind_sessions/sess_udmkkaabrvt0dhjrt7d0gbui46